Abstract
Long-Term Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have